{"id":324,"date":"2008-11-09T02:22:03","date_gmt":"2008-11-09T07:22:03","guid":{"rendered":""},"modified":"2022-01-22T13:24:59","modified_gmt":"2022-01-22T18:24:59","slug":"research-on-the-neurobiology-of-alcohol-use-disorders","status":"publish","type":"post","link":"https:\/\/www.internetandpsychiatry.com\/wp\/books\/books-available\/research-on-the-neurobiology-of-alcohol-use-disorders\/","title":{"rendered":"Research on the Neurobiology of Alcohol Use Disorders"},"content":{"rendered":"<p><a href=\"http:\/\/www.amazon.com\/gp\/product\/1604561971?ie=UTF8&amp;tag=internetandpsychiatry-20&amp;linkCode=as2&amp;camp=1789&amp;creative=9325&amp;creativeASIN=1604561971\"><img decoding=\"async\" style=\"margin: 5px; float: left;\" src=\"\/images-v01\/41q4RSzos3L._SL160_.jpg\" alt=\"alt\" border=\"0\" \/><\/a><img loading=\"lazy\" decoding=\"async\" style=\"border: none !important; margin: 0px !important;\" src=\"http:\/\/www.assoc-amazon.com\/e\/ir?t=internetandpsychiatry-20&amp;l=as2&amp;o=1&amp;a=1604561971\" alt=\"alt\" width=\"1\" height=\"1\" border=\"0\" \/>This book describes the neurobiological mechanisms of alcohol abuse and dependence including the role of serotonergeic, dopaminergic, noradrenergic, and hypothalamic-piturary adrenal systems in alcohol use disorders and the results of neuroimaging studies are presented. The neurobiology of comorbidity of alcohol use disorders with other psychiatric disorders is also discussed. Research on the neurobiology of alcohol abuse and dependence is very important. Therefore, this book will be of interest to biomedical researchers, physicians, and other clinicians, students, and anyone who is interested in the mechanisms of addictive disorders.<\/p>\n<p style=\"text-align: left;\">\u00a0<\/p>\n<p><!--more--><\/p>\n<p style=\"text-align: left;\"><span style=\"font-family: verdana,geneva;\"><\/p>\n<p><strong>Publisher:<\/strong> Nova Science Publishers<\/p>\n<p><strong>Editor:<\/strong> Leo Sher, M.D.<\/p>\n<p><strong>Contributors:<\/strong><\/span><\/p>\n<p>Norberto Bilbeny, M.D., Garbil Pharma Investigaci\u00f3n Chile, Santiago, Chile<\/p>\n<p>Selfa Contreras, Pharm.D., Garbil Pharma Investigaci\u00f3n Chile, Santiago, Chile<\/p>\n<p>Randall L. Davis, Ph.D., Neuroinflammation Research Laboratory, Department of Pharmacology\/Physiology, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA<\/p>\n<p>Nicholas Floreani, B.S., Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA<\/p>\n<p>Mar\u00eda Font, Ph. D., Pharm.D., D.Biol.Sci., Unit of Molecular Modelling, Faculty of Pharmacy, University of Navarra, Pamplona, Spain<\/p>\n<p>Hern\u00e1n Garcia, Pharm.D., Garbil Pharma Investigaci\u00f3n Chile, Santiago, Chile<\/p>\n<p>Christoph von der Goltz, M.D., University of Heidelberg, Dept. of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Mannheim, Germany<\/p>\n<p>James Haorah, Ph.D., Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA<\/p>\n<p>Andreas Heinz, M.D., Department of Psychiatry and Psychotherapy of the Charit\u00e9 &#8211; University Medical Center, Campus Charit\u00e9 Mitte, Berlin, Germany<\/p>\n<p>Susumu Higuchi, M.D., Ph.D., National Hospital Organization Kurihama Alcoholism Center, Yokosuka, Kanagawa, Japan<\/p>\n<p>George A. Kenna, Ph.D., R.Ph. Department of Psychiatry, Brown University, Providence, RI, and The Westerly Hospital, Westerly, RI, USA<\/p>\n<p>Falk Kiefer, M.D., University of Heidelberg, Dept. of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Mannheim, Germany<\/p>\n<p>Thorsten Kienast, M.D., Department of Psychiatry and Psychotherapy of the Charit\u00e9 &#8211; University Medical Center, Campus Charit\u00e9 Mitte, Berlin, Germany<\/p>\n<p>John H. Krystal, M.D., Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA<\/p>\n<p>Nita Makhija, Ed.M., Department of Psychiatry, Columbia University, and New York State Psychiatric Institute, New York, NY, USA<\/p>\n<p>Rosanna Mancinelli, Biol. Sci. D., Department of Environment and Primary Prevention, Istituto Superiore di Sanit\u00e0, Roma, Italy<\/p>\n<p>Ann M. Manzardo, Ph.D., Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, Kansas City, KS, USA<\/p>\n<p>Ezio Manzato, M.D.,Department of Addiction Medicine, Hospital &#8220;Chiarenzi&#8221; of Zevio, Verona, and Italian Society of Addiction Medicine (FeDerSerD), Milan, Italy<\/p>\n<p>Sachio Matsushita, M.D., National Hospital Organization Kurihama Alcoholism Center, Yokosuka, Kanagawa, Japan<\/p>\n<p>Milagros M\u00e9ndez, Ph.D., Departamento de Neuroqu\u00edmica, Subdirecci\u00f3n de Investigaciones Cl\u00ednicas, Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente, M\u00e9xico D.F., M\u00e9xico<\/p>\n<p>Jose Javier Miguel-Hidalgo, Ph.D., Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, USA<\/p>\n<p>Marcela Morales-Mulia, Ph.D., Departamento de Neuroqu\u00edmica, Subdirecci\u00f3n de Investigaciones Cl\u00ednicas, Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente, M\u00e9xico D.F., M\u00e9xico<\/p>\n<p>Stephanie A. Morris, B.S., Department of Pharmaceutical Sciences, The University of Kentucky, Lexington, KY, USA<\/p>\n<p>Felice Nava, M.D.,Department of Addiction Medicine, Hospital of Castelfranco Veneto, Treviso, and Italian Society of Addiction Medicine (FeDerSerD), Milan, Italy<\/p>\n<p>Kimberly Nixon, Ph.D., Department of Pharmaceutical Sciences, The University of Kentucky, Lexington, KY, USA<\/p>\n<p>Carlos Paeile, D.D.S., Garbil Pharma Investigaci\u00f3n Chile, Santiago, Chile<\/p>\n<p>Elizabeth C. Penick, Ph.D., Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, Kansas City, KS, USA<\/p>\n<p>Yuri Persidsky M.D., Ph.D., Departments of Pharmacology and Experimental Neuroscience, and Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA<\/p>\n<p>Carmen Rasmussen, Ph.D., Department of Pediatrics, University of Alberta and Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada<\/p>\n<p>Sungwon Roh, M.D., Ph.D., National Hospital Organization Kurihama Alcoholism Center, Yokosuka, Kanagawa, Japan<\/p>\n<p>Gunter Schumann, M.D., Institute of Psychiatry, Kings College, London, UK<\/p>\n<p>Leo Sher, M.D., Department of Psychiatry, Columbia University, and New York State Psychiatric Institute, New York, NY, USA<\/p>\n<p>Peter J. Syapin, Ph.D., Alcohol and Brain Research Laboratory, Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA<\/p>\n<p>Roberta J. Ward, Ph.D., Biologie du Comportement, Universit\u00e9 Catholique de Louvain, Louvain-la-Neuve, Belgium<\/p>\n<p>Philippe De Witte, Ph.D., Biologie du Comportement, Universit\u00e9 Catholique de Louvain, Louvain-la-Neuve, Belgium<\/p>\n<p>Katy Wyper, B.Sc., Department of Pediatrics, University of Alberta and Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada<\/p>\n<p style=\"text-align: left;\">\u00a0<\/p>\n<p class=\"MsoNormal\">\u00a0<\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This book describes the neurobiological mechanisms of alcohol abuse and dependence including the role of serotonergeic, dopaminergic, noradrenergic, and hypothalamic-piturary adrenal systems in alcohol use disorders and the results of neuroimaging studies are presented. The neurobiology of comorbidity of alcohol use disorders with other psychiatric disorders is also discussed. Research on the neurobiology of alcohol [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-324","post","type-post","status-publish","format-standard","hentry","category-books-available","has-post-title","has-post-date","has-post-category","has-post-tag","has-post-comment","has-post-author",""],"builder_content":"","_links":{"self":[{"href":"https:\/\/www.internetandpsychiatry.com\/wp\/wp-json\/wp\/v2\/posts\/324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.internetandpsychiatry.com\/wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.internetandpsychiatry.com\/wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.internetandpsychiatry.com\/wp\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.internetandpsychiatry.com\/wp\/wp-json\/wp\/v2\/comments?post=324"}],"version-history":[{"count":1,"href":"https:\/\/www.internetandpsychiatry.com\/wp\/wp-json\/wp\/v2\/posts\/324\/revisions"}],"predecessor-version":[{"id":3644,"href":"https:\/\/www.internetandpsychiatry.com\/wp\/wp-json\/wp\/v2\/posts\/324\/revisions\/3644"}],"wp:attachment":[{"href":"https:\/\/www.internetandpsychiatry.com\/wp\/wp-json\/wp\/v2\/media?parent=324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.internetandpsychiatry.com\/wp\/wp-json\/wp\/v2\/categories?post=324"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.internetandpsychiatry.com\/wp\/wp-json\/wp\/v2\/tags?post=324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}